I haven't been happy with Epivax from the beginning. The founder gave a misleading description of the peptide vaccine by mistakenly saying the drawback to peptide vaccines was the long manufacturing process. She never refers or gives a nod to GNBT or NGIO when talking about potential vaccines. The absence of GNBT in her statements leads me to believe Epivax is more of a contractor and less of a partner in GNBT's effort.

Also, Joe's ,"we are far ahead of many in the vaccine race" isn't the same as, "we are leading the vaccine race." This is disappointing - although this is admittedly taken out of context. Hopefully, there is more potential than appears.